[Glycemic control and diabetic complications].
Yamada
Yuichiro
Y
Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine.
D001645:Biguanides / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage
D001645:Biguanides; D015415:Biomarkers; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds